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ABSTRACT 
This article presents the potentiometric method of determination of chlorides using the original BO-05 electrochemical 
microanalyzer. The quantification of chlorides is one of the frequently performed methods, both in the indirect 
determination of active pharmaceutical ingredients (API) and impurities in pharmaceutical raw materials, 
pharmacopoeial substances or pharmaceutical formulations as well. Successfully validated method was used to the 
analysis of chlorides in the preparations containing verapamil hydrochloride in form of tablets Staveran® and 
Verapamil®. The mean content of the studied API calculated to one tablet was close to the declared and equal to 
123.6±1.5 mg and 122.6±1.1 mg, respectively. The presence of excipients have no significant impact on the final 
results. Thus shown that the electrochemical microanalyzer BO-05 is suitable for scientific, didactic and analytical 
applications. 
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1. INTRODUCTION 
The BO-05 microanalyzer combines both the functions of a potentiometer with high internal resistance and 
a potentiostat. The innovative BO-05 analyzer was constructed with the use of electronic devices and 
programmed appropriately for analytical purposes, using various types of sensors and microsensors, both 
scientific and educational. The analysis includes such methods as: potentiometry, stripping potentiometry, 
linear sweep voltammetry, anodic stripping voltammetry or chronoamperometry. The constructed 
microanalyzer is connected to a computer via the R-232 port which allows the manual and automatic 
control. Both the software and the equipment used minimize the amount of data necessary for the correct 
performance of the analysis and enabling quick online presentation of results. Direct connection with MS 
Office Excel enables immediate analysis of the obtained results and significantly improves the necessary 
calculations.  
Verapamil (2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-
ylpentanenitrile;hydrochloride – Fig. 1) is currently one of the most widely used anti-arrhythmic drugs 





, it is used in doses of 40, 80 or 120 mg. 






Figure1. The chemical structure of verapamil 
 
Verapamil is determined by various analytical techniques e.g. chromatographic [5-8], spectrophotometric 
[1], spectrofluorometric [9,10], voltamperometric [11], amperometric [12]. Verapamil with hydrochloride, 
in the studied pharmaceutical preparations, is present in a molar ratio of 1:1 [7]. Therefore, it is possible to 
determine the content of verapamil based on the amount of chlorides in this preparation. To determine the 
chloride content, a precipitimetric method with a potentiometric end point detection was used. Standard 
solutions containing chlorides were titrated with silver nitrate(V) solution in the platinum electrode system 
as indicator and silver chloride electrode as reference. In this work, an attempt was made to indirectly 
determine the content of verapamil in the studied drugs, based on the analysis of the content of an 
equivalent amount of chlorides. 
 
2. MATERIALS AND METHODS 
2.1. Materials  
Used in the research potassium nitrate (KNO3) and concentrated nitric acid (HNO3) were both Suprapur 
Merck. Water (quadruple-distilled) with a conductivity of less than 1 μS/cm was obtained using an S2-
97A2 distillation apparatus (ChemLand, Stargard Szczecin, Poland). The Staveran
®
 (Medana Pharma SA) 
and Verapamil
®
 (Mylan Pharmaceuticals Inc.) drugs were obtained in a local pharmacy. 






All potentiometric measurements were performed using a homemade BO-05 analyser (Fig. 2). 
 
Figure 2. The image of the Electrochemical Microanalyser BO-05 
The analyzer has been constructed using electronic components and programmed to be suitable for 
scientific, didactic and analytical applications using various electrochemical sensors and micro-sensors. 
The techniques accessible in the BO-05 analyzer include: various potentiometric methods, potentiometric 
stripping analysis, linear sweep voltammetry, anodic stripping voltammetry and chronoamperommetry. 
The input impedance for potentiometer was greater than 10
15
 ohms and the input current was lower than 
0.1 pA. For driving potentiostat circuitry, potential range is ±8 V, 2 mV potential resolution and 10 ms 
timing template are typical working parameters. The work of the analyzer is controlled manually and 
communicated with the computer by the RS-232 port. The applied hardware and software arrangement 
minimizes number of necessary data interchange transactions during measurement procedure and enables a 
true on-line presentation of measurement results.  
The presented system for electrochemical analyses consists of three separate hardware modules: the 
analyzer BO-05, a desktop or mobile computer and electrodes stand.  
The block diagram of BO-05 analyzer is shown on Fig. 3. 






Figure 3. Block diagram of analyzer type BO-05. WE -working electrode; RE -reference electrode; CE -counter/auxiliary 
electrode; PB -power booster; VF -voltage follower; S -switch of potentiostat mode (two or three electrode) 
The analyzer consists of the following functional subassemblies (modules): a) power supply, b) 
communication interface, c) analog to digital converters, d) potentiometer, e) potentiostat and current-to-
voltage converter. Once measurement procedure is in progress the only data transmitted to host computer 
are results of analog to digital conversions and other data necessary to presentation of results in a form of 
measurement curve. The potential waveform, through low pass filter drives inverting input of summing, 
first amplifier of the potentiostat (U1). The output signal of the summing amplifier is than current-boosted 
(PB) and flows to counter/auxiliary electrode (CE) of electrochemical cell. Reference electrode (RE) and 
high input impedance amplifier (U2) close feedback loop of the potentiostat providing summing current 
without disturbing the potential of the reference electrode. Configuration switch (S) enables selection of 
potentiostat mode: two or three electrode. Feedback loop amplifier (U2) and reference electrode (RE) are 
used in three-electrode configuration only, while in two-electrode configuration, seldom used, counter 
electrode serves as quasi-reference electrode. The current that flows through working electrode (WE) as an 
effect of processes inside the electrochemical cell is further amplified in I/E converter (U3). Value of R and 
C elements in a feedback loop of I/E converter determine the instrument’s sensitivity and are selected prior 
to measurement execution by configuration reed relay connectors. There are 5 full-scale ranges available 
from 10 nA to 10 mA, and they allow for precision adjust of the instrument’s sensitivity with regard to the 
monitored process. An output low-pass filter is used to suppress high frequency noise generated (in analog 
circuitry, cell and cables) on ADC input. High performance amplifiers (AD744 by Analog Devices) are 
used in the analyzer’s analog circuitry with exception of current booster (OPA627 by Burr Brown). 






Before starting the analysis, 20 tablets of the each preparation under study were weighed and ground in a 
porcelain mortar. The obtained powder was partially accurately weighed and transferred quantitatively to a 
50 mL volumetric flask and filled to the mark with quadruple-distilled water. The resulting solution was 
filtered. 
5 mL of 1 M KNO3 was added to the first of the measuring cell, and an appropriate amount of the sample 
solution, 20 µl of concentrated HNO3 and quadruple-distilled water were added to the second one 
measuring cell. Half-cells were connected with each other using an electrolytic key filled with 10% agar 
gel and 0.1 M KNO3. 0.001 M AgNO3 solution was added in equal portions to the measuring cell with the 
API under study at 10 s intervals. The SEM measurement of the measuring cell was recorded at 10 s 
intervals. Thus, 15 to 25 readings were obtained depending on the concentration of verapamil in the 
sample. The titration end point was determined automatically by the Hahn's method. The analyzes were 
performed in the Pt platinum electrode and Ag/AgCl silver chloride electrode. 
The obtained results were developed with the use of a proprietary program Metex-bis, written in a Visual 
Basic. The statistical analysis was performed using the Statistica 10.0 program and the Microsoft Excel 
2010 spreadsheet. 
3. RESULTS 
3.1. Method validation 
3.1.1. Precision  
To check the precision of the method at one level, stock solution containing chlorides was prepared. Then, 
100 µL of this solution with 50 µL of concentrated nitric acid were added into the measuring cell and filled 
with quadruple-distilled water up to 5 mL. The chlorides content in analyzed samples calculated to 
verapamil hydrochloride was 0.8 µg – Tab. 1. Fig. 4 shows examples of titration curves. 
Table 1. Results from method validation. Precision. 
No sample [g] 
calculated 
amount [g] 





















Figure 4. Examples of titration curves obtained for the same concentrations of standard chloride solutions 
3.1.2. Linearity 
To determine the linearity, 6 solutions at concentration in the range of 0.1 mmol/L - 1 mmol/L were 
prepared. The results were analyzed using the linear regression method. The regression equation and the 
correlation coefficient were as follows: y[V] = 0.1372+1.9857×c; R=0.9995. 
3.1.3. Limit of detection and Limit of quantification 
Using standard deviation and slope of a straight line coefficient. The values of LOD and LOQ were 
determined and equal to 0.1 μg and 0.32 μg respectively. 
3.1.4. Specificity 
Due to the similar properties of chlorides to iodides and bromides and the possibility of their presence next 
to each other. their influence on the end point of titration was investigated. The graph below shows the 
titration curves obtained for chlorides next to iodides and bromides. The method can be considered 
specific, because the PK values are clearly separable – Fig. 5. 






Figure 5. a) titration curve of chlorides in the presence of iodides and bromides; b) plot of the first derivative of the above 
determination 
3.1.5. Accuracy 
Recovery was calculated on the basis of determined content of verapamil hydrochloride to amount added to 
working solutions. The results are summarized in Tab. 2: 
Table 2. The results of the recovery obtained for the Staveran® preparation and their statistical evaluation. 
sample % recovery x̅ SD %RSD 
1 99.65 






3.2. Analysis of pharmaceutical preparations  




 in the form of tablets were analyzed. The 
manufacturer's declared content of verapamil hydrochloride in each tablet is 120 mg. The obtained results 
of chlorides content in the weighted portion of prepared samples enabled to determine the content of 
verapamil in samples under study – Tab. 3. In the next step, the calculated amounts were converted into the 





 - Tab. 4. 
 
 













SD %RSD n 
613.2 309.0 315.8 12.8 4.06 6 
604.4 304.6 318.4 12.7 4.00 6 
605.3 305.0 318.2 9.6 3.00 6 
849.7 298.26 307.3 4.7 1.52 6 
850.7 298.61 311.1 5.2 1.66 6 
782.0 274.50 289.2 6.5 1.68 6 




average amount per  
1 tablet [mg] 
SD %RSD n 
Staveran
®
 120 mg 123.6 1.46 1.1 6 
Verapamil
®
 120 mg 122.6 1.08 0.88 6 
4. CONCLUSIONS 
Due to the obtained results, it can be concluded that the analytical method using the BO-05 microanalyzer 
is an effective and reliable in the indirect determination of verapamil in selected pharmaceutical 
preparations. Under conditions of experiment, the method featured high sensitivity, good precision and 
comparability of results as proven by the method validation and statistical analysis of the results. The 
presence of excipients in the formulation have no significant impact on the results. Due to the low cost and 
relatively short duration of the analysis as well as the significant automation. This method can be proposed 
as comparable to other methods of determining of drugs. 
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